Research Topics
Species | Luca ArcainiSummaryAffiliation: University of Pavia Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Prognostic assessment in patients with indolent B-cell lymphomasLuca Arcaini
Division of Hematology, Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy
ScientificWorldJournal 2012:107892. 2012..In this paper we summarized the current evidence regarding prognostic assessment of indolent follicular and non-follicular lymphomas...
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasmsLuca Arcaini
Departments of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy
Blood 119:188-91. 2012..We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition...
Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous diseaseLuca Arcaini
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Viale C Golgi 19, Pavia 27100, Italy
Eur J Haematol 83:165-74. 2009..We also summarize the clinical features and outcome of this rare lymphoma and we discuss the possible association with hepatitis C virus infection...
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatmentLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy
Leuk Res 30:277-82. 2006..Aim of this study was to validate the FLIPI score in an independent series of follicular lymphoma patients and to correlate prognostic categories with the period of diagnosis and the use of anthracycline...
Splenic marginal zone lymphoma: a prognostic model for clinical useLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy
Blood 107:4643-9. 2006..In conclusion, with the use of readily available factors, this prognostic index may be an effective tool for evaluating the need for treatment and the intensity of therapy in an individual patient...
Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease disseminationLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy
Oncologist 11:285-91. 2006..This study describes the clinical features and the natural history of nongastric marginal-zone lymphomas and highlights that the dissemination to lymph nodes and bone marrow is associated with a poorer outcome...
Role of the molecular staging and response in the management of follicular lymphoma patientsLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy
Leuk Lymphoma 47:1018-22. 2006..Absence of the bcl-2 rearrangement is related to a better EFS and the achievement of a molecular response in peripheral blood after therapy is associated with a better EFS...
Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphomaL Arcaini
Division of Hematology, Fondazione IRCCS Policlinico S Matteo, University of Pavia, Pavia
Ann Oncol 19:1331-5. 2008..To evaluate the clinical outcome of patients with relapsed or refractory follicular lymphoma treated with immunochemotherapy, in vivo purging and high-dose therapy with autotransplant...
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALTL Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy
Ann Oncol 18:346-50. 2007....
Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern ItalyLuca Arcaini
Division of Hematology, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy
Clin Cancer Res 13:182-6. 2007..The aim of this study was to define the risk of second cancer in nongastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT)...
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphomaLuca Arcaini
Division of Hematology, Department of Oncohematology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Italy
Clin Lymphoma Myeloma Leuk 11:103-5. 2011..In conclusion, despite similar outcomes of these 2 entities, SMZL appears as a disease with distinct clinical features and BM histology and a peculiar association with HCV infection...
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomasLuca Arcaini
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Italy
Curr Clin Pharmacol 5:74-81. 2010....
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasLuca Arcaini
Divison of Hematology, Fondazione IRCCS Policlinico S Matteo, University of Pavia, Viale Golgi 19, Pavia, Italy
Am J Hematol 85:46-50. 2010..This could be a limit to the application of immunochemotherapy programs. HCV+ lymphomas represent a distinct clinical subset of NHL that deserves specific clinical approach to limit liver toxicity and ameliorate survival...
Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: a REL (Rete Ematologica Lombarda) experienceLuca Arcaini
Division of Hematology, Department of Oncohematology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Leuk Res 35:712-4. 2011..In conclusion, plerixafor combined with G-CSF allows a collection of adequate number of PBSC in approximately 40% of cases of poor mobilizer, heavily pre-treated pts with lymphoma, who need consolidation with ASCT...
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profilesLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy
Cancer 100:107-15. 2004..Splenic and nodal marginal zone lymphomas (MZL) are subtypes of marginal zone-derived neoplasms. Due to their rarity, little is known concerning their relation, pattern of dissemination, and treatment outcome...
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphomaL Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Bone Marrow Transplant 34:175-9. 2004..Immunochemotherapy prior to mobilization produces B-cell depletion and seems to be a useful preparative step...
Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphomaLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy
Clin Lymphoma 4:250-2. 2004..The immunochemotherapy regimen was well tolerated and all patients exhibited complete remission. To our knowledge, this is the first report of splenic MZL showing response to a combination of rituximab with chemotherapy...
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare diseaseLuca Arcaini
Division of Haematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Br J Haematol 136:301-4. 2007..In univariate analysis worse OS was associated with: FLIPI (P = 0.02), age > 60 years (P = 0.05) and raised lactate dehydrogenase (P = 0.05). In multivariate analysis, only FLIPI predicted a worse OS (P = 0.02)...
Blast phase of essential thrombocythemia: A single center studyFrancesco Passamonti
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Am J Hematol 84:641-4. 2009..JAK2 (V617F)-positive ET may evolve in few instances into JAK2-negative leukemia. The outcome of patients is poor whatever the treatment used...
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosisFrancesco Passamonti
Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Italy
Blood 111:3383-7. 2008..In conclusion, leukocytosis at diagnosis of PV is a risk factor for evolution in post-PV MF. A dynamic score based on hemoglobin level, and platelet and leukocyte count predicts survival at any time from diagnosis of post-PV MF...
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlationsEmanuela Boveri
Department of Surgical Pathology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Br J Haematol 140:162-8. 2008..003), and anaemia (P < 0.001) independently correlated with MVD. In summary, this study indicates that assessment of BM angiogenesis, as measured by MVD, may be a useful additional tool in the histopathological definition of CMD...
Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoiresLuca Arcaini
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia Viale C Golgi 19, 27100 Pavia, Italy
Blood Cells Mol Dis 42:286-91. 2009....
Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphomaMario Lazzarino
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Oncology 68:146-53. 2005..Because of the different mechanisms of action and non-overlapping toxicities, combination of rituximab with chemotherapy is a rational approach...
Long-term follow-up of young patients with essential thrombocythemia treated with pipobromanFrancesco Passamonti
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, Pavia, Italy
Ann Hematol 83:495-7. 2004
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patientsElisa Rumi
Division of Hematology, Department of Hematology Oncology, University of Pavia Medical School and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Haematologica 96:454-8. 2011..No difference in familial clustering was observed between the two groups...
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometryMichele Merli
Department of Oncohematology, Fondazione IRCCS Policlinico S Matteo, University of Pavia, Italy
Eur J Haematol 85:405-15. 2010..In FL, diffuse large B-cell lymphoma (DLBCL) and LPL, FC underestimates the extent of infiltrate with respect to histology...
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-upErcole Brusamolino
Clinica Ematologica and Servizio di Radioterapia Oncologica, Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Matteo, University of Pavia, Pavia, Italy
Clin Cancer Res 12:6487-93. 2006..To report on long-term events after short doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) chemotherapy and adjuvant radiotherapy in favorable early-stage Hodgkin's lymphoma...
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patientsFrancesco Passamonti
M D, Division of Hematology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy
Haematologica 93:1645-51. 2008..Essential thrombocythemia is a chronic myeloproliferative disorder; patients with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia...
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disordersElisa Rumi
Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia School of Medicine, Pavia, Italy
Cancer 107:2206-11. 2006..Thus, a genetic predisposition to acquisition of JAK2 (V617F) is inherited in families with myeloproliferative disorders...
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipationElisa Rumi
Department of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Viale Golgi 49, 27100 Pavia, Italy
J Clin Oncol 25:5630-5. 2007..However, familial clustering is reported. The purpose of this study was to assess the prevalence and the clinical phenotype of familial CMDs, and to study the anticipation of disease onset in successive generations...
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSSChiara Elena
Department of Hematology Oncology, Division of Hematology, University of Pavia Medical School and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Haematologica 96:167-70. 2011..This study suggests that red blood cell transfusion-dependency should be considered to improve risk stratification of primary myelofibrosis during follow up...
High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphomaFrancesca Novara
Department of Human end Hereditary Pathology, Section of Medical Genetics, University of Pavia, Pavia 27100, Italy
Hum Pathol 40:1628-37. 2009..01) and del(17p) (P = .02). Hepatitis C virus-positive splenic marginal zone B-cell lymphoma patients have no specific chromosome alterations. Patients with poor prognosis are characterized by distinctive imbalances...
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasmsMarzia Varettoni
Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Blood 121:2522-8. 2013..In this latter condition, MYD88 (L265P) is associated with greater disease burden and higher risk of disease progression, and the mutation may therefore also represent a useful prognostic marker...
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disordersFrancesco Passamonti
Department of Hematology, IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Blood 107:3676-82. 2006..This exemplifies a novel paradigm in which a somatic gain-of-function mutation is initially responsible for clonal expansion of hematopoietic cells and later for their abnormal trafficking via an activated cell progeny...
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemiaFrancesco Passamonti
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy
Haematologica 88:13-8. 2003..The aim of this study was to define the long-term risk of thrombosis, acute leukemia (AL) and myelofibrosis with myeloid metaplasia (MMM) in young PV patients...
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemiaFrancesco Passamonti
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Am J Med 117:755-61. 2004..To assess life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia...
An insidious presentation of splenic marginal zone lymphomaSara Burcheri
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy
Clin Lymphoma Myeloma 7:432-3. 2007..After the splenectomy, the blood cell count normalized, and neither BM nor peripheral blood involvement appeared after 12 months of follow-up...
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletionMarco Lucioni
University of Pavia Medical School, Istituti di Ricovero e Cura a Carattere Scientifico, San Matteo, Italy
Blood 118:4591-4. 2011....
A paraumbilical lymphomatous massSara Burcheri
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Eur J Haematol 77:180. 2006
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphomaDavide Rossi
Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Blood 118:4930-4. 2011..Genetic lesions of NF-κB provide a molecular basis for the pathogenesis of more than 30% of SMZLs and offer a suitable target for NF-κB therapeutic approaches in this lymphoma...
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapyLuca Arcaini
Department of Hematology Oncology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy
Clin Dev Immunol 2012:638185. 2012....
Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settingsMario B Regazzi
Department of Pharmacology, Clinical Medicine IRCCS Policlinico San Matteo, Pavia, Italy
Ther Drug Monit 27:785-92. 2005..Because several studies reported an association between response and serum Rituximab concentrations, a treatment based on a pharmacokinetic model may be useful for predicting the desired drug concentration...
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutationFrancesco Passamonti
Department of Hematology, University of Pavia Medical School, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Policlinico San Matteo, Pavia, Italy
Blood 110:485-9. 2007..A relationship was found between JAK2 (617V>F) and fetal loss (P = .05). This study indicates that patients carrying the JAK2 (617V>F) mutation have higher risk of developing pregnancy complications...
Leukemic transformation of polycythemia vera: a single center study of 23 patientsFrancesco Passamonti
Division of Hematology, IRCCS San Matteo Polyclinic, University of Pavia, Pavia, Italy
Cancer 104:1032-6. 2005..Acute leukemia (AL) may occur as rare and late event of polycythemia vera (PV)...
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision makingLuca Malcovati
Division of Hematology, IRCCS, Policlinico San Matteo, 27100 Pavia, Italy
J Clin Oncol 23:7594-603. 2005..MDS with isolated erythroid lineage dysplasia identifies a subset of truly low-risk patients, for whom a conservative approach is advisable...
CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single caseMarco Lucioni
Anatomic Pathology, Foundation IRCCS Policlinico San Matteo and University of Pavia, 27100 Pavia, Italy
Hum Pathol 42:1204-8. 2011..Search for t(11;14) with fluorescence in situ hybridization probes should always be performed in doubtful cases...
Marginal zone-related neoplasms of splenic and nodal originLuca Arcaini
Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy
Haematologica 88:80-93. 2003..Treatment options are heterogeneous, including a watch-and-wait policy, surgery with or without chemotherapy, purine analogs, and interferon. No prospective studies have been conducted so far...
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphomaSilvia Zibellini
Division of Hematology, Department of Oncohematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Viale Golgi 19, Pavia, Italy
Haematologica 95:1792-6. 2010..Overall, data suggest that the pathogenesis of splenic marginal zone lymphoma may involve also HCV-unrelated epitopes or an antigenic trigger common to other indolent lymphomas...
B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institutionMarco Lucioni
Anatomic Pathology Section, Department of Human Pathology, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy
Transplantation 82:1013-23. 2006..The EBV-negative cases with GC histogenetic phenotype showed a slightly better outcome; however, such less aggressive prognostic trend was not confirmed by statistical analysis...
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationDavide Rossi
Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Blood 117:3391-401. 2011..0%; P = .009). The molecular dissection of RS into biologically distinct categories highlights the genetic heterogeneity of this disorder and provides clinically relevant information for refining the prognostic stratification of patients...
A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myelomaAlessandro Corso
Division of Hematology, Istituto scientifico San Matteo, University of Pavia, Italy
Haematologica 87:1041-5. 2002..The purpose of this study was to compare the efficacy and toxicity of two regimens for peripheral blood stem cell (PBSC) mobilization in multiple myeloma (MM) patients...
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy?Luciano Bernardi
Department of Internal Medicine, University of Pavia and IRCCS Ospedale S Matteo, Pavia, Italy
Eur J Appl Physiol 99:511-8. 2007..Respiratory adaptations induced by the practice of yoga may represent an efficient strategy to cope with altitude-induced hypoxia...
Novel agents in indolent lymphomasMichele Merli
Division of Hematology, Department of Internal Medicine, Ospedale di Circolo and Fondazione Macchi, University of Insubria, Varese, Italy
Ther Adv Hematol 4:133-48. 2013..The development of these new drugs may change in the near future the approach to iNHL patients, leading to better tolerated and effective therapy regimens...
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experienceDaniele Vallisa
Department of Oncology and Hematology, G da Saliceto Hospital, Piacenza, Via Taverna 49, 29100 Piacenza, Italy
J Clin Oncol 23:468-73. 2005..The biologic mechanisms underlying the lymphomagenic activity of the virus so far are under investigation. In this study, the role of antiviral (anti-HCV) treatment in B-NHL associated with HCV infection is evaluated...
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphomaAlessandro Rambaldi
Divisione di Ematologia, Ospedali Riuniti Largo Barozzi 1, 24100, Bergamo, Italy
Blood 105:3428-33. 2005..006). RQ-PCR performed at presentation on BM samples predicts treatment response and long-term clinical outcome in patients with follicular lymphoma...
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infectionAchille Ambrosetti
Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
Br J Haematol 126:43-9. 2004..The close association of SGML with either autoimmune diseases or HCV infection in our series (73%) confirms their possible role in the pathogenesis of these lymphomas...
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphomaAlessandro Rambaldi
Divisione di Ematologia, Ospedali Riuniti Bergamo, Largo Barozzi 1, 24100 Bergamo, Italy
Blood 99:856-62. 2002..001)...
Management of primary mediastinal B-cell lymphoma with sclerosis: advances and caveatsLuca Arcaini
Haematologica 87:1238-9. 2002
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemiaElisa Rumi
Leuk Lymphoma 48:805-7. 2007
